Study for the Treatment for CLN7 Disease
NCT04737460 is a phase 1 interventional trial sponsored by Benjamin Greenberg. As of 21 Nov 2026, it is active and no longer recruiting. It studies CLN7. The registry lists an enrollment of 4 participants at 1 site in 1 country. The registry lists a start date of 4 May 2021 and a primary completion date of 1 Feb 2028.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04737460 |
| Status | Active not recruiting |
| Phase | Phase 1 |
| Study type | Interventional trial |
| Lead sponsor | Benjamin Greenberg |
| Enrollment | 4 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | CLN7 |
| Start | 4 May 2021 |
| Primary completion | 1 Feb 2028 |
| Study completion | 1 Feb 2029 |
| Last update posted | 31 Dec 2025 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Benjamin Greenberg, MD
University of Texas Southwestern Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children' Health
Dallas
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04737460
Each answer restates registry values shown on this page.
What is NCT04737460?
NCT04737460 is a phase 1 interventional trial sponsored by Benjamin Greenberg. It studies CLN7.
Is NCT04737460 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT04737460?
The registry names Benjamin Greenberg, MD (principal investigator, University of Texas Southwestern Medical Center) as the overall official.
Where does NCT04737460 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT04737460 expected to complete?
The registry lists a primary completion date of 1 Feb 2028 and a study completion date of 1 Feb 2029. The sponsor last updated the record on 31 Dec 2025.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.